We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$768M
AUM Growth
-$80.1M
Cap. Flow
-$27.1M
Cap. Flow %
-3.53%
Top 10 Hldgs %
60.99%
Holding
740
New
85
Increased
91
Reduced
143
Closed
103

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$1.75M
2
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
+$1.16M
3
LYFT icon
Lyft
LYFT
+$989K
4
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$721K
5
XYL icon
Xylem
XYL
+$522K

Top Sells

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$11.3M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$9.09M
3
KMX icon
CarMax
KMX
+$5.75M
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$2.77M
5
MSFT icon
Microsoft
MSFT
+$2.09M

Sector Composition

Rank Sector Weight
1 Financials 25.36%
2 Technology 10.73%
3 Consumer Discretionary 9.26%
4 Communication Services 3.87%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFC icon
351
Truist Financial
TFC
$64.6B
$29K ﹤0.01%
543
-4,030
-88% -$200K
UA icon
352
Under Armour Class C
UA
$2.82B
$29K ﹤0.01%
1,610
– –
CBT icon
353
Cabot Corp
CBT
$4.36B
$28K ﹤0.01%
624
– –
CG icon
354
Carlyle Group
CG
$17.9B
$28K ﹤0.01%
+1,113
New +$26.6K
LHX icon
355
L3Harris
LHX
$53.3B
$28K ﹤0.01%
+136
New +$27.8K
REGN icon
356
Regeneron Pharmaceuticals
REGN
$79.1B
$28K ﹤0.01%
100
– –
SYBT icon
357
Stock Yards Bancorp
SYBT
$2.63B
$28K ﹤0.01%
761
+6
+0.8% +$219
SGEN
358
DELISTED
Seagen Inc. Common Stock
SGEN
$28K ﹤0.01%
330
– –
CME icon
359
CME Group
CME
$95.2B
$27K ﹤0.01%
129
– –
EMR icon
360
Emerson Electric
EMR
$90.6B
$27K ﹤0.01%
398
-1,099
-73% -$69.1K
WBD icon
361
Warner Bros
WBD
$65.1B
$26K ﹤0.01%
1,000
– –
RDS.B
362
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$26K ﹤0.01%
419
+110
+36% +$6.57K
COR icon
363
Cencora
COR
$61.7B
$25K ﹤0.01%
312
– –
HBI
364
DELISTED
Hanesbrands
HBI
$25K ﹤0.01%
1,644
– –
ITW icon
365
Illinois Tool Works
ITW
$85.5B
$25K ﹤0.01%
160
+1
+0.6% +$152
LW icon
366
Lamb Weston
LW
$7.33B
$25K ﹤0.01%
349
– –
MOS icon
367
The Mosaic Company
MOS
$7.44B
$25K ﹤0.01%
1,223
– –
VTV icon
368
Vanguard Morningstar Value ETF
VTV
$191B
$25K ﹤0.01%
220
– –
MMP
369
DELISTED
Magellan Midstream Partners, L.P.
MMP
$25K ﹤0.01%
+372
New +$24.5K
CGC
370
Canopy Growth
CGC
$393M
$24K ﹤0.01%
105
– –
F icon
371
Ford
F
$56.3B
$24K ﹤0.01%
2,625
– –
MDY icon
372
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$24K ﹤0.01%
69
– –
NTLA icon
373
Intellia Therapeutics
NTLA
$1.53B
$24K ﹤0.01%
1,814
– –
FRC
374
DELISTED
First Republic Bank
FRC
$24K ﹤0.01%
+245
New +$23.2K
AZN icon
375
AstraZeneca
AZN
$250B
$23K ﹤0.01%
255
– –
13 14
15
16 17

Similar funds

CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
API
Advisor Partners II Walnut Creek, California $2.49B AUM 30.88% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
SCH
Sylebra Capital (HK) Hong Kong $1.88B AUM 19.75% 1-Year Est. Return
PWAG
Polaris Wealth Advisory Group San Rafael, California $1.31B AUM 17.95% 1-Year Est. Return
CS
Comerica Securities Detroit, Michigan $1.2B AUM 16.58% 1-Year Est. Return
IWP
Icon Wealth Partners Houston, Texas $880M AUM
MAM
Mastrapasqua Asset Management Nashville, Tennessee $853M AUM 37.36% 1-Year Est. Return

Pathstone Family Office's Q3 2019 Portfolio in Review

As of Q3 2019, Pathstone Family Office held 740 positions worth $768M, down 9.5% from $848M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Pathstone Family Office withdrew a net $27.1M in Q3 2019, closing 103 positions and reducing 143 holdings. Its most notable exit was UroGen Pharma, an estimated $1.47M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Pathstone Family Office opened a new position in Xylem worth $529K.

  • Pathstone Family Office's largest Q3 2019 buy was Xylem: 6,643 shares worth $529K.
  • Pathstone Family Office added most to Vanguard S&P 500 ETF in Q3 2019, an estimated $1.75M increase.
  • Pathstone Family Office's biggest Q3 2019 reduction was Royal Bank of Canada, cutting an estimated $11.3M.
  • Pathstone Family Office fully exited UroGen Pharma in Q3 2019, selling an estimated $1.47M.
  • Pathstone Family Office's ten largest holdings make up 61% of its $768M portfolio in Q3 2019.
  • Pathstone Family Office opened 85 new positions and closed 103 in Q3 2019.
  • Pathstone Family Office's portfolio value fell 9.5% quarter-over-quarter to $768M.

Based on Pathstone Family Office's 13F filing for Q3 2019, filed 13 Nov 2019.